Medical Market Report

Global Bipolar Disorder Market By Type (Selective Serotonin Reuptake Inhibitor, Serotonin Norepinephrine Reuptake Inhibitors, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, Benzodiazepines, and Beta Blockers), By Application (Mood Stabilizers, Anticonvulsants, Antipsychotic drugs, Antidepressant drugs, and Antianxiety drugs), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 138067
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global Bipolar Disorder Market is estimated to be valued US$ XX.X million in 2019. The report on Bipolar Disorder Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global bipolar disorder market is segmented on the basis of Type, Application, and geography.

    Europe market was valued at US$ XX.X million in 2018 and is projected to reach US$ XX.X million in 2029, and register a CAGR of X.X% during the forecast period, according to a new Market.us (Prudour Research) study.

    Bipolar Disorder Market Scope:

    By type, the market is segmented into Selective Serotonin Reuptake Inhibitor, Serotonin Norepinephrine Reuptake Inhibitors, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, Benzodiazepines, and Beta Blockers. By Application, the market is divided into Mood Stabilizers, Anticonvulsants, Antipsychotic drugs, Antidepressant drugs, and Antianxiety drugs.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Glaxo SmithKline (GSK), Pfizer, Janssen Pharmaceuticals, Eli Lilly, Allergan, Novartis, AbbVie, Otsuka, and AstraZeneca.

    Key Market Segments

    Type

    Selective Serotonin Reuptake Inhibitor

    Serotonin Norepinephrine Reuptake Inhibitors

    Tricyclic Antidepressants

    Monoamine Oxidase Inhibitors

    Benzodiazepines

    Beta Blockers

    Application

    Mood Stabilizers

    Anticonvulsants

    Antipsychotic drugs

    Antidepressant drugs

    Antianxiety drugs

    Key Market Players included in the report:

    Glaxo SmithKline (GSK)

    Pfizer

    Janssen Pharmaceuticals

    Eli Lilly

    Allergan

    Novartis

    AbbVie

    Otsuka

    AstraZeneca

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Bipolar Disorder Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Bipolar Disorder Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Bipolar Disorder Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Bipolar Disorder Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Bipolar Disorder Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Bipolar Disorder Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Bipolar Disorder sub-markets, depending on key regions (various vital states).
    To analyze Bipolar Disorder Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Bipolar Disorder Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide Bipolar Disorder Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Bipolar Disorder Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players3. Global Bipolar Disorder Market Overview
    

    3.1. Bipolar Disorder Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges  3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy4. Global Bipolar Disorder Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Bipolar Disorder Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Selective Serotonin Reuptake Inhibitor
    

      4.4. Serotonin Norepinephrine Reuptake Inhibitors
    

      4.5. Tricyclic Antidepressants
    

      4.6. Monoamine Oxidase Inhibitors
    

      4.7. Benzodiazepines
    

      4.8. Beta Blockers5. Global Bipolar Disorder Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Bipolar Disorder Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Mood Stabilizers
    

      5.4. Anticonvulsants
    

      5.5. Antipsychotic drugs
    

      5.6. Antidepressant drugs
    

      5.7. Antianxiety drugs6. Global Bipolar Disorder Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Bipolar Disorder Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Bipolar Disorder Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Bipolar Disorder Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Bipolar Disorder Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Bipolar Disorder Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    
7. Global Bipolar Disorder Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Glaxo SmithKline (GSK)
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments  7.4. Pfizer
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments  7.5. Janssen Pharmaceuticals
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments  7.6. Eli Lilly
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments  7.7. Allergan
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments  7.8. Novartis
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments  7.9. AbbVie
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments  7.10. Otsuka
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments  7.11. AstraZeneca
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.